Efficacy and Safety of Transcatheter Valve-in-Valve Implantation for Failing Bioprosthetic Valve - Efficacy and Safety of Transcatheter Valve-in-Valve Implantation for Failing Bioprosthetic Valve

Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine0 个研究点目标入组 5 人开始时间: 2015年8月1日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. history of coronary infarction within previous 1 month 2. PCI or PTA within previous 1 month 3-1. WBC<1000 3-2. Plt<50000 3-3. history of coagulation disorder 3-4. hyper coagulability state 4. untreated coronary artery disease requiring revascularization 5. cardiac shock or state requiring mechanical support 6. emergent operation 7. EF <20% 8. CVA or TIA within previous 1 month 9. active gastrointestinal bleeding 10. 1 Aspirin, 2 ticlopidine hydrochloride, 3 heparin, 4 contrast agents, 5 Nitinol was contraindication. 11. active endocarditis 12. refusal of blood transfusion 13. life expectancy less than 12 months due to associated non-cardiac comorbid condition 14. severe dementia 15. participation of other clinical trial 16. carotid or vertebral artery stenosis with symptoms 17. Heart team is not agree regarding medical, social, or psychological state 18. at least 1 cardiovascular surgeon and 1 cardiologist are not agree regarding anatomical findings. 19. HCM 20. presence of vegetation 21. HOCM 22. potential of coronary obstruction

发起方

Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine